Steward Health Care System

Return to Results

A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015

new search

Trial Conditions
  • Venous Leg Ulcer
  • Venous Stasis Ulcer
What is the purpose of this trial?

The objective of this study is to examine the durability of previous target wound closures, identify new test article-related adverse events, record new target wound closures, and examine ongoing adverse events not resolved in subjects who participated in HP 802-247-09-015.

Date & Status

Completed

Who can Participate?

Eligibility

Ages:
18 and older

Gender:
Both

Eligibility

INCLUSION CRITERIA:

- Provide informed consent

- Willing to comply with protocol instructions, including allowing all study
assessments.

- Subject was randomized in HP 802-247-09-015 and received at least one application of
a test article, whether active or placebo.

- Subject has ended their participation in HP 802-247-09-015 by virtue of completing
the study, or by dropping out prior to completion.

Exclusion Criteria

- Subjects who refuse to provide written informed consent will be excluded from this
trial.

Gender: Both
Steward Physician(s)
  • Hebert B Slade, MD, FAAAAI
Facilities
  • New England Sinai Hospital - Completed
Physician Researcher

Investigator Name:

  • Hebert B Slade, MD, FAAAAI

Other Information

Sponsor: Healthpoint
Phase: N/A
Trial ID: NCT00900029
Volunteers:  Not Accepting Healthy Volunteers

new search

Connect with Steward

Visit Our Twitter Feed Visit Our Facebook Page Email This Page Print This Page

Subscribe to our patient e-newsletter

Copyright © 2014 Steward Health Care
Connect Healthcare Panacea CMS Solutions